Shenzhen - Delayed Quote • CNY
Sino Biological,Inc. (301047.SZ)
At close: April 26 at 3:04 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
646,388.50
646,388.50
574,603.39
965,272.54
1,596,293.02
Cost of Revenue
115,976.54
115,976.54
86,037.77
58,239.86
49,787.66
Gross Profit
530,411.96
530,411.96
488,565.62
907,032.68
1,546,505.36
Operating Expense
366,524.54
366,524.54
261,019.11
127,947.39
188,803.09
Operating Income
163,887.43
163,887.43
227,546.52
779,085.28
1,357,702.27
Net Non Operating Interest Income Expense
42,799.41
42,799.41
57,843.65
11,852.61
-589.71
Pretax Income
287,948.71
287,948.71
342,512.75
845,452.10
1,313,106.00
Tax Provision
27,816.96
27,816.96
39,554.98
125,438.43
185,498.47
Net Income Common Stockholders
260,131.75
260,131.75
302,957.77
720,013.67
1,127,607.54
Basic EPS
2.01
2.01
2.66
12.71
11.64
Diluted EPS
2.01
2.01
2.66
12.71
11.64
Basic Average Shares
129,200.23
129,200.23
113,898.18
56,666.77
96,899.79
Total Operating Income as Reported
287,947.44
287,947.44
342,509.64
841,673.70
1,315,216.38
Rent Expense Supplemental
6,547.84
6,547.84
4,290.49
2,507.60
11,451.21
Total Expenses
482,501.07
482,501.07
347,056.87
186,187.26
238,590.76
Net Income from Continuing & Discontinued Operation
260,131.75
260,131.75
302,957.77
720,013.67
1,127,607.54
Normalized Income
278,108.93
278,108.93
310,989.16
733,229.22
1,147,235.90
Interest Income
46,942.48
46,942.48
60,955.96
14,398.10
285.12
Interest Expense
3,729.00
3,729.00
2,773.32
2,011.26
--
Net Interest Income
42,799.41
42,799.41
57,843.65
11,852.61
-589.71
EBIT
291,677.71
291,677.71
345,286.07
847,463.36
1,357,702.27
EBITDA
361,508.64
361,508.64
383,387.99
873,834.94
1,374,784.92
Reconciled Cost of Revenue
115,976.54
115,976.54
86,037.77
58,239.86
49,787.66
Reconciled Depreciation
69,830.92
69,830.92
38,101.92
26,371.58
11,320.08
Net Income from Continuing Operation Net Minority Interest
260,131.75
260,131.75
302,957.77
720,013.67
1,127,607.54
Total Unusual Items Excluding Goodwill
-19,899.56
-19,899.56
-9,079.99
-15,517.92
-22,857.35
Total Unusual Items
-19,899.56
-19,899.56
-9,079.99
-15,517.92
-22,857.35
Normalized EBITDA
381,408.20
381,408.20
392,467.98
889,352.87
1,397,642.26
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,922.37
-1,922.37
-1,048.60
-2,302.37
-3,228.99
12/31/2020 - 8/16/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade